Julius Clinical is intertwining its roots with those of Peachtree BioResearch Solutions. The two CROs are joining forces in efforts…

North Carolina-based CRO Fortrea is saying goodbye to its CEO. Thomas Pike is hitting the road effective May 13 and…

The Food and Drug Administration is going all in on artificial intelligence. Commissioner Martin Makary, M.D., has instructed all the…

Amid a chaotic biopharma ecosystem and declining revenues, Charles River Laboratories is initiating a strategic review and shaking up its…

Bulgarian CRO Comac Medical has found a new leader to guide the company's international expansion. Chris Smyth, Ph.D., is leaving…

Bayer is boosting its precision oncology efforts with a molecular database from health tech firm ConcertAI.  Under a multiyear deal,…

Chinese CRO GemPharmatech is building up its U.S. presence with a new San Diego space housing laboratories and a suite…

CenExel is the latest CRO to change ownership hands. Boston-based private equity firm BayPine has acquired a majority stake in…

The U.K. is rolling out new regulations meant to reduce red tape for clinical studies and boost the nation’s role…

The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal antibodies and…